Here you can see sales of our main Healthcare Business products. As illustrated on the previous page, DR products have grown significantly. CR strategic products also grew sharply. Sales of dry film are expanding outside Japan. As a result, we were able to sell almost the same volume as the year before. The increased profitability from subcontracting film that we had previously made in-house from the end of FY2012 also contributed to profits.